| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |